Drug Discovery World

APRIL 14, 2023

Dr Schon obtained his PhD in Cancer Research from The University of Cambridge before joining Sir Greg Winter’s biotech venture Domantis in 2003 which was acquired by GSK three years later. Biography Oliver Schon, PhD, has been VP, R&D at BiVictriX Therapeutics since September 2021.

Drug Development 130

Drug Development Drugs Clinical Trials Therapies 130

Drug Target Review

AUGUST 26, 2024

In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge. Raminderpal earned his PhD in semiconductor modelling in 1997. For more: [link] ; [link] ; [link] ; [link]

Science 59

Science Research Marketing 59

The Pharma Data

NOVEMBER 5, 2020

The number of drug addicts who developed vision-endangering eye infections quadrupled between 2003 and 2016,… Source link. THURSDAY, Nov. 5, 2020 — America’s ongoing opioid epidemic is costing increasing numbers of addicts their eyesight, a new study reports.

Disease 40

Disease Drugs 40

Drug Discovery World

NOVEMBER 7, 2022

In April 2003, after its launch in October 1990, the project was completed, generating the first sequence of the human genome. One might argue that this all started getting exciting with the launch of the Human Genome Project, which the National Human Genome Research Institute consider to be one of the greatest scientific feats in history 1.

Therapies 246

Therapies DNA Disease Research 246

LifeSciVC

JANUARY 12, 2024

It’s also not feeling like the nuclear winter of 2002-2003 either, where venture-backed biotech was starving. Stepping back from the specifics of these data, the venture funding market for private biotech companies feels like it’s returned to a healthier place than the bubblicious euphoria of a few years ago.

Marketing 112

Marketing Science 112

Drug Target Review

AUGUST 14, 2024

In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge. Raminderpal earned his PhD in semiconductor modelling in 1997. For more: [link] ; [link] ; [link] ; [link]

Engineering 59

Engineering Science Drugs Research 59

Drug Target Review

SEPTEMBER 24, 2024

In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge. Raminderpal earned his PhD in semiconductor modelling in 1997. For more: [link] ; [link] ; [link] ; [link]

Government 59

Government Science Research Drugs 59

Common Sense for Drug Policy Blog

NOVEMBER 29, 2023

Strang, Beswick and Gossop, 2003 ; Wakeman et al. There is ample evidence from the U.S. and elsewhere that longer-term non-MOUD treatments place those who relapse at an especially high risk of opioid overdose and death.( There is also compelling evidence that agonist MOUD decreases opioid-involved and all-cause mortality ( Santo et al.

Treatment 52

Treatment Drugs 52

Drug Target Review

JUNE 20, 2024

In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge. Raminderpal earned his PhD in semiconductor modelling in 1997. For more: [link] ; [link] ; [link]

Science 64

Science Research Marketing Drugs 64

The Pharma Data

NOVEMBER 17, 2020

1, 2003, and Dec. Zaira Aversa, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues conducted a population-based cohort study involving children born in Olmsted County, Minnesota, between Jan. 31, 2011, to examine the impact of antibiotic exposure in the first two years of life.

Therapies 52

Therapies Doctors Disease Research 52

The Pharma Data

OCTOBER 15, 2020

from NYU School of Medicine in New York City, and colleagues examined longitudinal data from 2003 to 2015 in the Veterans Aging Cohort Study to examine the impact of reducing drinking among veterans with unhealthy alcohol use (AUDIT score ?8). THURSDAY, Oct. 15, 2020 — For U.S. 8 in Alcoholism: Clinical & Experimental Research.

Research 52

Research 52

The Pharma Data

AUGUST 13, 2020

Approximately 460,000 patients in the US have been treated with Xolair since its first approval for allergic asthma back in 2003. It is the only biologic approved which is designed to target and block immunoglobin E (IgE) for the treatment of moderate-to-severe persistent allergic asthma and chronic idiopathic urticaria (CIU).

FDA 52

FDA Clinical Development Treatment Therapies 52

The Pharma Data

OCTOBER 16, 2020

from Kosin University Gospel Hospital in South Korea, and colleagues used data from 732,199 individuals who had undergone a national health check-up in 2002 to 2003. Jihun Kang, M.D., Lung cancer incidence and mortality were identified, and associations with common medications (aspirin, metformin, and statins) were assessed.

Hospitals 52

Hospitals Research Drugs 52

Drug Target Review

MAY 15, 2024

In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge. Raminderpal earned his PhD in semiconductor modelling in 1997. For more: [link] ; [link] ; [link]

FDA Approval 59

FDA Approval FDA Science Marketing 59

Drug Target Review

SEPTEMBER 13, 2024

In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge. Raminderpal earned his PhD in semiconductor modelling in 1997. For more: [link] ; [link] ; [link] ; [link]

Science 59

Science Research Marketing Drugs 59

Common Sense for Drug Policy Blog

JANUARY 5, 2024

Our bodies follow circadian rhythms of approximately 24-hour cycles, and as Kamps warned me, these rhythms have an impact on our mental and metabolic health (Roenneberg et al.

Pharmacy 52

Pharmacy Regulations Production Marketing 52

The Pharma Data

JANUARY 15, 2021

years, which was lower than any year since 2003. Life expectancy was estimated for the total U.S. population and by race and ethnicity. The researchers found that the medium estimate indicated a 1.13-year year reduction in U.S. life expectancy at birth to 77.48 year reduction in life expectancy was projected at age 65 years.

Science 52

Science Research 52

Drug Target Review

MAY 24, 2024

In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge. Raminderpal earned his PhD in semiconductor modelling in 1997. For more: [link] ; [link] ; [link]

RNA 59

RNA DNA Bioinformatics Science 59

Drug Target Review

JUNE 24, 2024

In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge. Raminderpal earned his PhD in semiconductor modelling in 1997. For more: [link] ; [link] ; [link]

Science 69

Science Engineering Research Marketing 69

The Pharma Data

OCTOBER 27, 2020

For the study, the researchers analyzed data from more than 350,000 women who were born between 1985 and 2003, and lived in 43 countries in sub-Saharan Africa, South and Southeast Asia, Latin America and the Caribbean.

Science 52

Science Research 52

Common Sense for Drug Policy Blog

JUNE 4, 2023

2003 ) and strong results from RIOTT indicating improved outcomes for ‘treatment refractory’ people (i.e. Despite a robust international evidence base for the social and health benefits of HAT ( Haasen et al., 2007 ; March, Oviedo-Joekes, Perea-Milla, & Carrasco, 2006 ; Oviedo-Joekes et al., 2010 ; van den Brink et al.,

Treatment 40

Treatment International Government Trials 40

PLOS: DNA Science

JUNE 13, 2024

For perspective, SARS-CoV-2’s genome is only about 80% similar to that of the original SARS coronavirus from 2003. The first SARS virus, from 2003, doesn’t have a furin cleavage site, but HIV, the Ebola virus, and the MERS coronavirus do. RaTG13 shares about 96.1% of its genome sequence with that of SARS-CoV-2.

Virus 52

Virus RNA DNA Science 52

The ChEMBL-og

MARCH 28, 2023

For example, NEFAZODONE HYDROCHLORIDE was withdrawn in 2003 from Canada for causing adverse hepatic events. CELECOXIB which has not been withdrawn for all indications, DIETHYLSTILBESTROL which is still used to treat prostate cancer, etc).

Drugs 52

Drugs FDA 52

The Pharma Data

NOVEMBER 3, 2020

MRIs were used to examine the brains of 311 newborns in the Early Brain Development Study at the University of North Carolina between 2003 and 2016. TUESDAY, Nov. Of those newborns, 26% were found to have asymptomatic subdural hemorrhages (bleeding in and around the brain).

Research 52

Research 52

Common Sense for Drug Policy Blog

AUGUST 22, 2023

Drug Checking Services "One of the consequences of drug prohibition is the lack of knowledge regarding the composition and purity of illicit substances ( Miron, 2003 ; Taylor et al.,

Drugs 40

Drugs 40

The Pharma Data

OCTOBER 21, 2020

Founded in 2003, Athenex, Inc. The live conference call and replay can also be accessed via audio webcast at the Investor Relations section of the Company’s website, located at [link]. About Athenex, Inc.

Engineering 52

Engineering Therapies International Treatment 52

The Pharma Data

MARCH 17, 2021

Nally has been at Merck since 2003 and served in a number of roles with increasing responsibilities including the managing director of the company’s U.K., Michael Nally has served as chief marketing officer for Human Health since January 2019, following three years leading Merck’s global vaccines business.

Research Laboratories 52

Research Laboratories Laboratories Marketing Vaccine 52

LifeSciVC

NOVEMBER 30, 2023

As a historical comparison, in the post-Genomics-Bubble aftermath from 2001-2003, the public biotech sector only shrank 7% despite similarly loud calls for consolidation, according to data in E&Y Reports from that time.

Marketing 111

Marketing Government Production 111

The Pharma Data

SEPTEMBER 8, 2021

For example, in 2001 with anthrax and 2003 with SARS-CoV1, TIB Molbiol demonstrated their ability to develop PCR assays for the detection of new pathogens within days.

Virus 52

Virus Assay Development Disease Research 52

The Pharma Data

JANUARY 18, 2021

The issuance or the subscription of the securities of the Company may be subject to legal and regulatory restrictions in certain jurisdictions; none of Biophytis and the bank involved in the ADS Offering assumes any liability in connection with the breach by any person of such restrictions.

Regulations 40

Regulations Clinical Trials Production Disease 40

Agency IQ

NOVEMBER 20, 2023

EPA publishes draft Meaningful Involvement Policy The Environmental Protection Agency has released a draft of its Meaningful Involvement Policy, an update of a 2003 policy, which seeks to improve the interactions of the agency with stakeholders about agency actions.

Regulations 40

Regulations Government International Science 40

The Pharma Data

JANUARY 25, 2021

The company was founded in 2003 based on innovative research from Uppsala University , Sweden. BioArctic AB (publ) is a Swedish research-based biopharma company focusing on disease-modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease.

Pharmaceutical Companies 40

Pharmaceutical Companies Disease Treatment Pharmaceuticals 40

The Pharma Data

APRIL 14, 2021

with Xolair since its initial approval in 2003. “The possibility of administering FDA-approved treatment outside of the healthcare provider’s office, but still guided by that healthcare provider, may reduce barriers to care for patients and their caregivers.”. Approximately 460,000 patients have been treated in the U.S.

FDA Approval 52

FDA Approval Clinical Development FDA Licensing 52

The Pharma Data

NOVEMBER 17, 2021

Mike McDermott has been with Pfizer for 18 times having started with the Company in 2003 as head of also Wyeth’s Biotech Manufacturing Operations at its Pearl River, New York point. Over the times he has taken on places with adding situations of responsibility, and he was named President of Pfizer Global Supply in 2019.

Vaccine 52

Vaccine Production Government Treatment 52

Perficient: Drug Development

OCTOBER 3, 2023

Bill has led marketing at Perficient since 2003, in a period of intense growth. Bill Davis Senior Vice President, Marketing & Alliances As senior vice president of marketing and alliances, Bill Davis is responsible for Perficient’s global marketing and communications functions.

Engineering 52

Engineering Marketing Production 52

The Pharma Data

JANUARY 22, 2021

In the study, IIH rates increased sixfold in Wales between 2003 and 2017 — from 12 per 100,000 people to 76 per 100,000 people. . “Obese individuals are at greater risk for more frequent migraine, too,” noted Dr. Brian Grosberg, director of the Hartford HealthCare Headache Center in Connecticut. 20 issue of Neurology.

Hospitals 52

Hospitals Doctors Treatment Research 52

The Pharma Data

NOVEMBER 18, 2020

Since 2003, the organization has invested $126 million in pancreatic cancer research. . “And I had to be strong because she couldn’t see me weak or broken by the news — I wanted to give her hope.” This year, it will invest $23 million toward its research initiatives. PanCAN is able to do this through donor support.

Disease 52

Disease Research Treatment Trials 52